title: Use of inflammatory markers to guide cancer treatment.
authors.affiliation: Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia. stephen.clarke@sydney.edu.au
authors.forename: S J
authors.initials: SJ
authors.lastname: Clarke
authors.forename: W
authors.initials: W
authors.lastname: Chua
authors.forename: M
authors.initials: M
authors.lastname: Moore
authors.forename: S
authors.initials: S
authors.lastname: Kao
authors.forename: V
authors.initials: V
authors.lastname: Phan
authors.forename: C
authors.initials: C
authors.lastname: Tan
authors.forename: K
authors.initials: K
authors.lastname: Charles
authors.forename: D C
authors.initials: DC
authors.lastname: McMillan
mesh_terms: D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis*; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein